Which No. 1 seed is king? Which middle seed could make a deep run? Here are the best teams at each seed line in the men's NCAA tournament. March Madness is here! That means it’s time to get down to ...

Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the ...

Add Yahoo as a preferred source to see more of our stories on Google. (Photo by Jessica Rinaldi/The Boston Globe via Getty Images) The Boston Globe will not print and deliver its paper Tuesday morning ...

When The Beatles broke up in 1969 (although it wasn’t announced until 1970), the four men made a point of moving forward into solo forays pretty quickly. They also inherently understood that their ...

On Earth, we can punch an address into Google Maps and be on our way in seconds. But plotting a course for NASA's Perseverance rover, 140 million miles away on Mars, is significantly more difficult.

It is hard to believe that I have been doing “First with Kids” for almost 29 years — but how time flies when you are having fun and trying to make a difference. This week is my 1,500th column! To ...

“In the day, we sweat it out on the streets / Of a runaway American dream / At night, we ride through mansions of glory / In suicide machines.” Straight out of the gate, this Springsteen classic packs ...

Only the most inherently negative observers could grade Jon Sumrall’s first week as anything less than an “A.” One subscription: The best Florida Gators coverage and community, and all access to the ...

WASHINGTON, Dec 3 (Reuters) - Six former Environmental Protection Agency employees on Wednesday filed a First Amendment legal challenge against EPA Administrator Lee Zeldin for terminating their ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. For anyone versed in the technical underpinnings of LLMs, this ...

Semaglutide or tirzepatide should be first-line drugs for obesity and most of its related complications, new guidance from the European Association for the Study of Obesity recommended. The authors of ...